Generation of various kinds of trans-mitochondrial mice, mito-mice, each carrying mtDNAs with a different pathogenic mutation, is required for precise investigation of the pathogenesis of mitochondrial diseases. This study used two respiration-deficient mouse cell lines as donors of mtDNAs with possible pathogenic mutations. One cell line expressed 45 -50% respiratory activity due to mouse mtDNAs with a T6589C missense mutation in the COI gene (T6589C mtDNA) and the other expressed 40% respiratory activity due to rat (Rattus norvegicus) mtDNAs in mouse cells. By cytoplasmic transfer of these mtDNAs to mouse ES cells, we isolated respiration-deficient ES cells. We obtained chimeric mice and generated their F 6 progeny carrying mouse T6589C mtDNAs by its female germ line transmission. They were respiration-deficient and thus could be used as models of mitochondrial diseases caused by point mutations in mtDNA structural genes. However, chimeric mice and mito-mice carrying rat mtDNAs were not obtained, suggesting that significant respiration defects or some deficits induced by rat mtDNAs in mouse ES cells prevented their differentiation to generate mice carrying rat mtDNAs.
INTRODUCTION
Human mtDNAs with large-scale deletions (DmtDNAs) and with point mutations have been identified to be closely associated with mitochondrial diseases expressing respiratory defects in various tissues (for reviews, see 1, 2) . Moreover, these mtDNA mutations have also been identified in association with human aging and with various age-related disorders including diabetes and neurodegenerative diseases (1, 2) . However, possible involvement of nuclear DNA mutations in expression of respiration defects was not excluded, as respiratory function is controlled by both nuclear DNA and mtDNA (1, 2) . Subsequent studies resolved this issue by providing direct evidence for the pathogenicity of mtDNA mutations in patients by co-transmission of the mutated mtDNAs and respiration defects from the patients to mtDNAless human cells (3 -6) .
However, even though mutated mtDNAs induced respiration defects, there is no direct evidence that respiration defects are responsible for the disease phenotypes found in patients with mitochondrial diseases. Therefore, it was still possible that nuclear DNA mutations induced expression of disease phenotypes. Our recent studies (7 -9) excluded this possibility by generating trans-mitochondrial mice, mito-mice, sharing the same nuclear-genome background but carrying various proportions of DmtDNAs with a 4696 bp deletion # The Author 2006. Published by Oxford University Press. All rights reserved.
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Disease phenotypes of the patients appeared to vary slightly depending on whether pathogenic mtDNA mutations are created in tRNA genes or in structural genes. For example, the former mutations are associated with CPEO, MELAS and MERRF, and the latter with Leber's disease, NARP, and Leigh syndrome, although all the mutations eventually induced respiration defects (1, 2) . Therefore, mito-mice carrying different pathogenic mutations in various genes of mtDNAs have to be generated to resolve the issue of whether differences in the mutation sites in mtDNAs are responsible for expression of different disease phenotypes. However, Figure 1 . Characterization of mtDNA donor cell lines carrying possible pathogenic mtDNAs. B82 cybrids of mtDNA donors to ES cells share the same nucleargenome background as that of mouse B82 cells derived from C3H strain mice (M. m. domesticus), but possess various mtDNAs. B82CyB6, B82CySpr and B82CyRn cells possess wild-type mtDNAs from M. m. domesticus, M. spretus and R. norvegicus, respectively. Parental B82 cells possess heteroplasmic M. m. domesticus mtDNAs with and without a missense T6589C mutation in the COI gene. B82COI W and B82COI M cells were obtained by recloning B82 cells and possess homoplasmic wild-type mtDNAs without T6589C mutation and homoplasmic T6589C-mutated mtDNAs, respectively. The genome composition of mouse cell lines used in this experiment is summarized in Table 1 M cells with mouse T6589C mtDNAs gave 86 and 39 bp fragments due to gain of an HhaI site by a T6589C mutation in the COI gene. Parental mouse B82 cells with both the wild-type and mutated mtDNAs gave all three fragments. On Southern blot analysis of HindIII digests, B82CyB6 cells with mouse (M. m. domesticus) mtDNAs and B82CyRn cells with rat (R. norvegicus) mtDNAs gave a 13.5 and a 4.1 kb fragment, respectively. (B) Analyses of respiratory function in B82 cells and their cybrids. B82CyB6 cells carrying nuclear genome from C3H strain mice and mtDNAs from B6 strain mice (M. m. domesticus) were used as standards expressing normal respiratory function. Asterisks indicate a P-value less than 0.05 and double asterisks indicate a P-value less than 0.005. (C) Analyses of respiratory function in P29 cybrids (cf. Table 1 ). P29CyB6 cells carrying nuclear genome and mtDNAs from B6 strain mice (M. m. domesticus) were used as standards expressing normal respiratory function. Asterisks indicate a P-value less than 0.05.
there are significant problems in generating mito-mice carrying various pathogenic mtDNAs.
One is the problem of isolating donor cells carrying mtDNAs with pathogenic mutations equivalent to those found in patients with mitochondrial diseases, because no procedures are thus far available for introduction of artificially mutagenized mtDNAs into mitochondria in living cells or even into isolated mitochondria. Therefore, there have been attempts to obtain mouse cell lines possessing mtDNAs with naturally occurring pathogenic mutations for use as mtDNA donors (7, 10, 11) . In addition to using such mutated mouse mtDNAs, in this study we tried to use rat mtDNA as a possible pathogenic mtDNA, because complete repopulation of mtDNAs in mouse cells by rat mtDNAs induced significant reduction of mitochondrial respiratory function (12 -14) , probably due to incompatibilities between mouse nuclear and rat mitochondrial genomes.
Another problem is the recipients of pathogenic mtDNAs for generation of mito-mice. In a previous study (7), we used mouse zygotes as DmtDNA recipients to generate mitomice carrying DmtDNAs, as it has the replication advantage of being predominant due to being smaller than recipient wildtype mtDNAs. However, mouse zygotes possess 5 Â 10 4 to 5 Â 10 5 copies of endogenous wild-type mtDNAs (15) and thus are not appropriate for use as recipients of mutated mtDNAs, particularly when pathogenic mtDNAs without replication advantage are to be introduced for generation of mito-mice carrying them. This problem could be resolved using ES cells as recipients of pathogenic mtDNAs, as they possess 3 Â 10 3 mtDNA genomes, which could be excluded by their pretreatment with the mitochondrial toxin rhodamine-6G (R6G) (16) . As inheritance of mtDNAs is strictly maternal (17, 18) , in this study we used XO-type mouse ES cells as recipients, and isolated respiration-deficient ES cells by cytoplasmic transfer of possible pathogenic mtDNAs from respirationdeficient mouse cell lines. Although karyotypic instability of XO-type ES cells used in this study could be a major problem for generation of trans-mitochondrial models, we obtained chimeric mice and generated mito-mice expressing respiration defects by germ line transmission of a mutated mtDNA from female chimeric mice to their progeny.
RESULTS
Characterization of mtDNA donor cell lines carrying mtDNAs with point mutations For generation of respiration-deficient mito-mice carrying mtDNAs with point mutations, we used cell fusion techniques to isolate ES cells with mtDNAs from two respiration-deficient mouse B82 cell lines and from one respiration-competent mouse B82 cell line. As these cells with nuclear genomes from B82 cells could not survive in the selection medium with hypoxanthine/aminopterin/thymidine (HAT), unfused cells were effectively eliminated from the fusion mixture and thus could be used as mtDNA donors for mouse ES cells.
A respiration-deficient mouse cell line B82COI M with homoplasmic T6589C-mutated mtDNAs in the COI gene (T6589C mtDNA) and a respiration-competent mouse cell line B82COI
W with homoplasmic wild-type mtDNAs were obtained by recloning parental mouse B82 cells possessing 35.3% T6589C mtDNAs (Fig. 1A) . The T6589C missense mutation, which changes the amino acid of the COI subunit from Val 421 to Ala, has been reported to be pathogenic (19) . Direct sequencing of whole mtDNAs in B82COI M and B82COI W cells showed that they shared the same mtDNA sequences except for a T6589C mutation in the COI gene.
Using B82CyB6 cells carrying B6 mtDNAs as normal standards of respiratory function and adenosine triphosphate (ATP) contents, we carried out biochemical analysis of respiratory function and found that B82COI M cells expressed 50% complex IV (cytochrome c oxidase; COX) activity, but expressed normal activities of other respiratory complexes (Fig. 1B) . Their ATP contents were 70% of those in B82CyB6 cells (Fig. 1B) , whereas B82COI W cells possessed normal ATP contents and expressed normal activities in all the respiratory complexes we tested (Fig. 1B) . Considering that COI is one of the COX subunits, all these observations suggest that respiration defects in B82COI M cells should be due to a pathogenic T6589C mutation in the COI gene.
Another respiration-deficient cell line B82CyRn, which carried nuclear DNA from mouse B82 cells (Mus musculus domesticus) and mtDNA from rat (Rattus norvegicus) (Fig. 1A and Table 1 ), expressed 40% COX activity and contained 15% ATP (Fig. 1B) . Therefore, rat mtDNAs could also be used as mtDNAs with possible pathogenic mutations in mouse cells. Such respiration defects observed in B82CyRn cells may be due to incompatibilities between the mouse The chromosome numbers obtained from 30 metaphase B82 cybrids and ES cybrids were 53 and 39, respectively, and were very stable irrespective of whether mouse mtDNA was replaced by rat mtDNA.
nuclear and rat mitochondrial genomes, because most respiratory complexes including COX consist of both nuclear DNA-and mtDNA-coded polypeptides. A respiration-competent mouse cell line B82CySpr with nuclear DNA from mouse B82 cells (M. m. domesticus) and mtDNAs from a different mouse species M. spretus ( Fig. 1A ) retained normal respiratory function and normal ATP contents (Fig. 1B) and was used as a donor of normal mtDNAs with polymorphic mutations.
Statistically significant correlation coefficients between cybrids with T6589C mtDNAs and rat mtDNAs were not observed in COX activity, but observed in ATP contents (Fig. 1B) . Similar results were obtained when we used mouse P29 cybrids sharing B6 nuclear background different from that of B82 cybrids (Table 1 and Fig. 1C ).
Isolation of respiration-deficient ES cells by introduction of mutated mtDNAs
The ES cells (XO-type TT2-F cells) used as recipients of exogenous mtDNAs were pretreated with R6G to eliminate endogenous mitochondria and mtDNAs (16) , and fused with enucleated mtDNA donor cells (B82CySpr cells, B82COI M cells and B82CyRn cells; cf. Table 1 ) to obtain mtDNA-repopulated ES cells. Then, the fusion mixture was cultivated in HAT medium to eliminate mtDNA donor cells, which possess HAT-sensitive nuclear genomes. Unfused ES cells could not survive due to the absence of mitochondria owing to their pretreatment with R6G. Thus, we could obtain either mtDNA-repopulated ES cells with exogenous mtDNAs from enucleated mtDNA donor cells, or parental ES cells, which restored remaining endogenous mtDNAs.
Growing colonies were cloned for examination of mtDNA genotypes (Fig. 2) . From the fusion mixture of R6G-pretreated ES cells and enucleated B82CySpr cells, we obtained six clones and found that they all possessed predominant amounts of M. spretus mtDNAs (Fig. 2B) . From the fusion mixture of R6G-pretreated ES cells and enucleated B82COI M cells, one clone, ESCOI M cells, which carried homoplasmic T6589C mtDNAs was isolated (Fig. 2C) . We also obtained six clones from the fusion mixture of R6G-pretreated ES cells and enucleated B82CyRn cells. Of the six clones, three clones (ESRn4 -6) possessed only rat mtDNAs, whereas the other three (ESRn1-3) possessed host mouse mtDNAs, which would be derived from remaining mouse mtDNAs in ES cells even after R6G pretreatment (Fig. 2D) .
We selected three mtDNA-repopulated ES clones, ESSpr1, ESCOI M and ESRn6 cells, in which mtDNAs were replaced by M. spretus mtDNAs, mouse T6589C mtDNAs and rat mtDNAs, respectively, for further examination. We examined their respiratory function by histochemical analysis (COX cytochemistry), but not by biochemical analysis, because it was difficult to prepare a sufficient number of mtDNA-repopulated ES cells (5 Â 10 6 cells) without contamination with the feeder cells for biochemical assay.
As expected, ESCOI M and ESRn6 cells showed respiration defects, whereas ESSpr1 cells had normal activity (Fig. 2) . These observations indicated that mtDNA genotypes and respiration phenotypes were transferred simultaneously from mtDNA donor cell lines to ES cells, and the resultant ESCOI M and ESRn6 cells could be used for generation of respiration-deficient mito-mice, whereas ESSpr1 cells could be used as normal controls (Fig. 2) .
Generation of founder mice and mito-mice carrying exogenous mutated mtDNAs
Three mtDNA-repopulated ES cell lines were introduced into 8-cell-stage embryos of ICR strain mice (M. m. domesticus). We obtained F 0 (founder) mice showing 100% chimerism from ESSpr1 and ESCOI M cells, but not from ESRn6 cells ( Table 2 ). On Southern blot (Fig. 3A) and polymerase chain reaction (PCR) analyses of tail mtDNAs (Fig. 3B) , founder mice showing 100% chimerism possessed 100% exogenous mtDNAs and were named founder Spr and founder COI M .
Then, females of founder Spr and founder COI
M showing 100% chimerism were mated with B6 males. As expected, all F 1 mice born from these founder mice showed the agouticoat color of the ES-derived phenotype (Table 2) . Moreover, mtDNA analysis showed that they possessed 100% M. spretus mtDNAs (Fig. 3A) or 100% T6589C mtDNAs in all tissues tested (Fig. 3B ). These observations provided convincing evidence that the F 1 mice corresponded to mito-mice carrying 100% exogenous mtDNAs. Then, F 1 female mitomice were back-crossed five times with B6 males and the resultant F 6 mito-mice carrying 100% T6589C mtDNAs and 100% M. spretus mtDNAs were named F 6 mito-mice COI M and F 6 mito-mice Spr, respectively (Table 1) .
However, on introduction of ESRn6 cells into 8-cell-stage embryos of ICR strain mice, no chimerism was found in any of the 24 individuals of founder mice ( Table 2 ). The absence of rat mtDNAs was confirmed by Southern blot analysis of tail mtDNAs from three founder mice (Fig. 3C) . One founder mouse, however, showed slight PCR signals for rat mtDNAs in the heart, kidney and tail (Fig. 3C) , although its coat color did not show chimerism. Direct sequencing of the PCR products showed that they corresponded to rat mtDNAs (Table 3) , suggesting the presence of a very small number of ESRn6-derived somatic cells. As they may also have trace amounts of oocytes derived from ESRn6 cells, and produce F 1 individuals carrying rat mtDNAs, we tried to generate mice carrying rat mtDNAs by mating founder females obtained from ESRn6 cells with B6 males. However, none of the 118 F 1 progeny (45 females and 73 males) examined had the agouti-coat color (Table 2 ). These observations suggested that respiration defects of ESRn6 cells with rat mtDNAs inhibited their differentiation to oocytes or that their respiration defects inhibited subsequent embryogenesis to F 1 progeny, even if they had been able to differentiate into oocytes carrying rat mtDNAs.
Examination of respiratory function and disease phenotypes in F 6 mito-mice COI M F 6 mito-mice COI M were used for further investigation of the pathogenesis, whereas B6 mice and F 6 mito-mice Spr were used as normal controls. As pathogenic controls, we used F 6 mito-mice D87, possessing 87% mtDNAs and co-expressing respiration defects and mitochondrial disease phenotypes. They were obtained by five times back-crossing of F 1 mitomice carrying DmtDNAs (7) with B6 males. Mito-mice D100 possessing homoplasmic DmtDNAs were not obtained due to its strong pathogenicity to induce complete loss of respiratory function (7), whereas F 6 mito-mice COI M possessing 100% T6589C mtDNAs survived, probably due to the weaker pathogenicity of the latter.
Cross-sections of heart from 6-month-old B6, F 6 mitomouse Spr, F 6 mito-mouse D87 and F 6 mito-mouse COI M were stained histochemically for examination of COX activity (Fig. 4A) . All cardiac cells in the heart from an F 6 mito-mouse COI M showed lower staining of COX activity than those from an F 6 mito-mouse Spr and a normal B6 mouse (Fig. 4A) . In contrast to an F 6 mito-mouse COI M , mosaic staining of COX activity was observed in the heart of an F 6 mito-mouse D87: 65% of cardiac cells did not stain for COX activity, whereas the remaining 35% showed normal staining. Quantitative PCR analysis of DmtDNAs in serial microdissection samples showed that the former cells possessed 89% DmtDNAs and the latter possessed 77% (data not shown). Variation in the amount of DmtDNAs and resultant variation of COX activity in an F 6 mito-mouse D87 would be due to random segregation of DmtDNAs (9). In contrast, homoplasmic T6589C mtDNAs in an F 6 mito-mouse COI M resulted in the uniform distribution of reduced COX activity in their cardiac cells (Fig. 4A) . Biochemical analysis of COX activity also decreased in the brain, heart, liver and skeletal muscles from F 6 mito-mice COI M (Fig. 4B) . Therefore, F 6 mito-mice COI M expressing respiration defects were used for the investigation of whether respiration defects caused by a point mutation of the COI gene in mtDNAs are responsible for the pathogenesis of mitochondrial diseases. As patients with respiration defects due to similar missense mutations in the COI (20) and COII genes (21) commonly expressed lactic acidosis, we examined this phenotype and observed increase in the amount of lactate in the blood of F 6 mito-mice COI M (Fig. 4C) . Moreover, F 6 mitomice COI M showed growth retardation (Fig. 4D) , suggesting that they can be used as models of mitochondrial diseases induced by point mutations in structural genes.
Effects of respiration defects of ES cells induced by mutated mtDNAs on their differentiation
The success in obtaining chimera and mito-mice from ESCOI M cells but not from ESRn6 cells suggested that rat mtDNAs preferentially inhibited multipotent ES cells from differentiating into various somatic cells and germ line cells. For testing this idea, the mtDNA-repopulated ES cells, ESSpr1, ESCOI M and ESRn6 cells, were inoculated subcutaneously into the back of nude mice.
All mtDNA-repopulated ES cells, except for ESRn6 cells with rat mtDNAs, formed tumors by 4 weeks after their inoculation. ESRn6 cells formed a small tumor in one of the three nude mice, but the growth of tumors decreased progressively in ESRn6 cells (Fig. 5, A1 -D1) . Moreover, histological analyses of their tumors showed that parental ES cells, ESSpr1 cells and ESCOI M cells differentiated into various tissues, such as secretory cells (Fig. 5, A2 -C2 ), bone cells (Fig. 5 , A3 -C3), striated muscles (Fig. 5, A4 -C4 ) and hair follicles (Fig. 5, A5 -C5 ). Thus, ESCOI M cells did not lose abilities for multipotent differentiation (Fig. 5, C1 -C5 ), even though they were respiration-deficient (Fig. 2C) . However, no tissues, except for secretory cells, were differentiated from ESRn6 cells (Fig. 5, D2 ). These observations suggest that rat mtDNAs or rat mtDNA-induced respiration defects in ES cells inhibited their proper differentiation and should be responsible for the failure to generate chimeric mice from ESRn6 cells (Table 2) .
DISCUSSION
Point mutations in the COI (20) and COII genes (21) of human mtDNAs were reported in patients with respiration defects and appeared to be commonly associated with lactic acidosis. In addition, one patient suffered epilepsy (20) and the other muscle weakness (21) . In human cases, however, patients carry various nuclear-genome backgrounds, which may affect disease phenotypes by inducing respiration defects or directly induce disease phenotypes. Therefore, it was difficult , PCR analysis was carried out using various tissues (right panel). Br, brain; H, heart; Lu, lung; P, pancreas; Li, liver; K, kidney; Tes, testis; Sk, skeletal muscles; Ta, tail. (C) Examination of rat mtDNAs in founder mice showing 0% chimerism (founder-1, -2, and -3) by Southern blot analysis of HindIII digests. No signal of a 4.1 kb fragment representing rat mtDNAs was observed in the tail of founder mice (left panel). However, PCR analysis using specific primers for selective amplification of rat mtDNAs gave signals of a 381 bp fragment corresponding to rat mtDNAs in the heart, kidney and tail of one founder mouse (founder-1), indicating the presence of a very small number of somatic cells carrying rat mtDNAs in the founder mouse showing 0% chimerism (right panel). Br, brain; H, heart; Sp, spleen; P, pancreas; Li, liver; K, kidney; Sk, skeletal muscles; E, ear lobe; Ta, tail.
to determine whether mtDNA mutations in the COI and COII genes are responsible for respiration defects. Moreover, even if mtDNA mutations in the COI and COII genes are responsible for respiration defects, it is also difficult to determine whether the respiration defects caused by the mtDNA mutations are responsible for disease phenotypes. However, mito-mice share the same nuclear-genome background and their genetic variations are restricted to their mtDNA mutations. Therefore, mito-mice could provide unambiguous evidence that the disease phenotypes, which were observed exclusively in the mito-mice, were due to respiration defects caused by the mtDNA mutations.
We generated F 6 mito-mice COI M using ES cells, and statistical analysis of the amounts of lactate in their blood showed that a missense T6589C mutation in the mtDNA COI gene alone is sufficient for clinical expression of lactic acidosis. However, these mice did not express epilepsy or muscle weakness, which were reported in patients carrying missense mutations in the COI gene (20) and COII gene (21), respectively. Probably, mtDNAs with less pathogenic mutations, such as the T6589C mutation, require cooperation with nuclear gene mutations for expression of disorders, such as epilepsy and muscle weakness.
Chimeric mice were not obtained from respiration-deficient mouse ESRn6 cells carrying rat mtDNAs (Fig. 3C) . Moreover, ESRn6 cells did not differentiate into various somatic tissues, whereas ESCOI M cells maintained multipotent properties when they were inoculated into the back of nude mice (Fig. 5 ). Although cybrids with rat mtDNAs and cybrids with mouse T6589C mtDNAs showed similar reduction of COX activity, rat mtDNAs provided only 15 -20% ATP contents in B82CyRn and P29CyRn cybrids, whereas mouse T6589C mtDNAs provided 70% ATP contents in B82CyCOI M and P29CyCOI M cells (Fig. 1B and C) . Preferential reduction of ATP contents in cybrids with rat mtDNAs would be due to multiple amino acid replacement induced by rat mtDNAs and resultant multiple mitochondrial dysfunction. Thus, it is possible to suppose that more than 20% of ATP contents is necessary for ES cells to show their proper differentiation and development into chimeric mice and for germ line transmission of the mutated mtDNAs in ES cells. However, it is also possible that rat mtDNAs specifically induced deficit in cell growth or predisposition to aneuploidy in mouse ES cells, resulting in the prevention of generation of mice carrying rat mtDNAs. The possible involvement of rat cytoplasmic factors encoded by rat nuclear genome derived from rat platelets in B82CyRn cells (14) was excluded because of their long-term cultivation after the fusion and resultant complete replacement by mouse cytoplasmic factors before introduction of their rat mtDNAs into mouse ES cells.
One approach to the question of whether the significant reduction of ATP contents was the main factor in the nontransmission of the rat mtDNAs would be to make cybrids with intermediate levels of rat mtDNAs. Previously, we introduced mouse mtDNAs into B82CyRn cybrids with only rat mtDNA and examined whether rat mtDNAs could propagate in mouse cells even in the presence of mouse mtDNAs (22) . The results showed that rat mtDNAs, which propagated stably and expressed mitochondrial dysfunction in mouse cells, disappeared rapidly on exogenous introduction of mouse mtDNAs, suggesting that rat mtDNAs could not propagate in the presence of mouse mtDNAs in mouse cells. Probably, mouse mtDNAs replicated preferentially under control of the mouse nuclear genome and the rejection of rat mtDNAs from mouse cells was due to the incompatibility between nuclear and mitochondrial genomes of different species.
Recently, maternal transmission of a homoplasmic mtDNA with a significant pathogenic mutation in tRNA
Val gene was reported to be responsible for multiple neonatal deaths in a family expressing mitochondrial diseases (23) . These observations suggested that female germ line cells with pathogenic mtDNAs could differentiate into various tissues. However, this study showed that mouse ES cells with rat mtDNAs did not differentiate into various tissues (Fig. 5) . This discrepancy could be explained by supposing that female germ line cells are more resistant to respiration defects than ES cells for their differentiation and this is why neonates are born from their respiration-deficient mother (23) .
Respiration-deficient mito-mice similar to F 6 mito-mice COI M have been generated from ES cells carrying a homoplasmic mitochondrial rRNA gene mutation, which gave a phenotype for resistance to chloramphenicol (CAP r ) and was responsible for 50% activity of normal respiratory function even in the absence of CAP (24) . Respiration-deficient CAP r mice showed various disorders, such as growth retardation and dilated cardiomyopathy, and died within 11 days after their birth (11), although there have been no reports of patients expressing mitochondrial diseases caused by CAP r mutations in mtDNAs, probably due to the instability of CAP r mutations. However, our F 6 mito-mice COI M showed lactic acidosis and this abnormality was also observed in patients carrying similar missense mutations to T6589C (20, 21) . Therefore, it appears to be arguable whether significant abnormalities were preferentially observed in CAP r mice, although both CAP r and T6589C point mutations in mtDNAs resulted in 50% activity of respiratory function. This problem might be explained by supposing that differences in mutation sites in human mtDNA genes sometimes resulted in the expression of very close but different abnormalities. For example, mutations in tRNA genes are responsible for MELAS, MERRF and cardiomyopathy, whereas mutations in structural genes induce Leigh syndrome and Leber's disease (1, 2) . Another explanation is that the difference of nucleargenome background of ES cells may affect disease phenotypes. The XO-type ES cells (CC9.3.1 cells) used for (11) were derived from 129 strain mice, whereas the XO-type ES cells (TT2-F cells) used in this study were from a B6CBAF1 embryo. Differences in the nuclear-genome backgrounds of ES cells could also explain why McKenzie et al. (25) did not isolate XO-type ES cells (CC9.3.1) carrying rat mtDNAs, but we obtained them (Fig. 2D) .
There are many disorders requiring both nuclear and mtDNA mutations for their expression. For example, the homoplasmic missense T3394C mutation in the ND1 gene of mtDNAs from a patient expressing diabetes and mitochondrial diseases (26) was also observed in a pedigree expressing maternally inherited cardiac abnormalities, but not expressing diabetes (27) . Thus, the specificity of disease phenotypes is determined and controlled by mutations in nuclear genes. Moreover, Johnson et al. (28) reported that thresholds of auditory-evoked brainstem response were slightly increased in A/J strain mice possessing nuclear DNA mutations in the age-related hearing loss (ahl ) locus by addition of a mutation in the mtDNA tRNA Arg gene. Similar cases of nuclear and mitochondrial cooperation for expression of hearing loss were reported in maternally inherited and non-syndromic congenital deafness (29, 30) and in mito-mice carrying more than 80% DmtDNAs (31). These observations suggest that hearing loss caused by nuclear gene mutation was enhanced by the addition of mtDNA mutations.
Therefore, mito-mice carrying various pathogenic mtDNA mutations and various nuclear-genome backgrounds have to be generated for precise investigation of the pathogenesis of mitochondrial diseases. We are now generating mito-mice COI M with different nuclear-genome backgrounds to prove the hypothesis that mtDNA mutations and resultant expression of respiration defects simply enhances the expression of disease phenotypes caused by nuclear DNA mutations (31) . We are also investigating aging effects on respiration defects and morphological abnormalities in aged F 6 mito-mice COI M .
MATERIALS AND METHODS

Cell culture and media
Mouse mtDNA-less (r 0 ) cell lines (32) and their mtDNArepopulated cybrids were grown in normal medium: RPMI 1640 (Nissui Seiyaku) containing 10% fetal calf serum, uridine (50 ng/ml) and pyruvate (0.1 mg/ml). Owing to the absence of thymidine kinase activity, mouse cells carrying nuclear genome from B82 cells could not survive in the presence of HAT. The ES cells used to generate mutant mice were TT2-F, an XO subline established from XY TT2 cells (33) . The ES cells and mtDNA-repopulated ES cells were cultivated on mitomycin C-inactived feeder cells derived from fetal fibroblasts. For their cultivation, we used ES medium consisting of Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 15% knockout serum replacement (Invitrogen), 1Â non-essential amino acids (ICN Biomedicals), leukemia inhibitory factor (10 5 U/ ml, Invitrogen), 100 mM 2-mercaptoethanol and gentamicin. The nuclear backgrounds of the mouse cells used in this study are summarized in Table 1 .
Production of mtDNA-repopulated ES cells
To isolate mtDNA-repopulated ES cells by exogenously introduced mtDNAs, we pretreated ES cells with R6G (0.75 -1.5 mg/ml 3% ethanol) for 48 h in ES medium supplemented with uridine (50 ng/ml) and pyruvate (0.1 mg/ml) to exclude endogenous mtDNAs. After R6G pretreatment, ES cells were washed with phosphate-buffered saline (PBS) and suspended in R6G-free medium for 2 h for recovery. Enucleated cells, i.e. cytoplasts, of mtDNA donor cells were prepared by their pretreatment with cytochalasin B (10 mg/ml) for 10 min and centrifugation at 13 000g for 38 min at 378C. The resultant cytoplasts were washed with PBS and incubated for 30 min. Then, the cytoplasts were fused with R6G-pretreated ES cells using polyethylene glycol. Fusion mixtures were plated onto fresh feeders and exposed to selective ES medium with HAT. Seven days after fusion, growing colonies were picked up for further examination. 
Chromosome analysis
Chromosome numbers in cybrids and ES cells were analyzed after colcemide (0.02 mg/ml) treatment and Giemsa staining. The chromosome numbers were obtained from 30 metaphase B82 cybrids and ES cybrids.
Generation of founder chimeric mice and mito-mice
Jcl:ICR females (6-week-old, Crea Japan) were superovulated by consecutive injections of pregnant mare serum gonadotropin (7.5 IU) and human chorionic gonadotropin (7.5 IU) with a 48 h interval between injections. They were caged overnight with fertile ICR males, and 8-cell-stage embryos were collected in M16 medium. About 15 mtDNA-repopulated ES cells were injected into the 8-cell-stage embryos. After cultivation in ES medium for 24 h, the embryos were transferred into pseudopregnant ICR females. The resultant progeny was identified by their coat color chimerism. For generation of F 1 progeny, founder (F 0 ) chimera females were mated with B6 males. F 1 progeny was back-crossed five times with B6 males, and F 6 generations were obtained for further analyses. The nuclear backgrounds of the mice used in this study are summarized in Table 1 . As a pathogenic control, we used F 6 mito-mouse D87, which was generated by five times back-crossing of F 1 mito-mice carrying DmtDNAs (7) with B6 males.
Southern blot analysis
Restriction fragments of total DNA or PCR products were separated on 1.0% agarose gel, transferred to a nylon membrane and hybridized with [a 32 P] dATP-labeled mouse or rat mtDNA probes. The membrane was washed and exposed to an imaging plate for 2 h. The radioactivities of the restriction fragments were measured with a bioimaging analyzer, Fujix BAS 2000 (Fuji PhotoFilm).
Analyses of mitochondrial respiratory function
Biochemical and histochemical analyses of complex IV (COX) activity were carried out by examining the rate of cyanide-sensitive oxidation of reduced cytochrome as reported (34) with slight modifications (35) . In histochemical analysis of COX activity, hearts were excised from the animals and cryosections of 10 mm thickness from the tissues were stained for COX activity. Biochemical analyses of complex I þ III activities were carried out as described previously (35) .
ATP measurement
Total cellular ATP contents were measured using 1 Â 10 4 cells plated in 12-well plates. Cells were lysed with 100 ml lysis buffer (Toyo ink) and placed directly into the chamber of a luminometer (Berthold). Light emission was recorded after addition of 100 ml of luciferin-luciferase solution (Toyo ink).
PCR analysis and sequencing
Total cellular DNA (0.2 mg) extracted from cultivated cells and tissues was used as a template. For detection of rat mtDNAs, the nucleotide sequences of the COI gene encoded by rat mtDNAs (GenBank Accession No. X14848) were used to make the oligonucleotide primers: 5 0 -GCTT CGGAAACTGACTTGTACC-3 0 and 5 0 -GCTGCTAATACT GGCAGTGAGA-3 0 , which corresponded to the nucleotide sequences from positions 5538 to 5559 and from 5919 to 5898, respectively. The cycle times were 60 s for denaturation at 948C, 60 s for annealing at 528C and 60 s for extension at 728C for 30 cycles. PCR products were separated by electrophoresis in 3% agarose gels containing ethidium bromide (0.1 mg/ml). PCR products were analyzed by direct sequencing in an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, California, MA, USA) using the Big Dye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems).
Detection of the T6589C mutation in COI gene was achieved by restriction fragment length polymorphism (RFLP) analysis. A 125 bp fragment was amplified by PCR with the following primers reported previously (1): 5 0 -CATGA GCAAAAGCCCACTTCGCCATCATATTCGTAGGcG-3 0 (a mismatch indicated by the lower case c) and 5 0 -TGTGGTGTAAGCATCTGGGTAG-3 0 , which corresponded to mouse mtDNA (GenBank Accession No. AY172335) sequences from positions from 6550 to 6588 and from 6674 to 6653, respectively. The cycle times were 60 s for denaturation at 948C, 60 s for annealing at 608C and 60 s for extension at 728C for 30 cycles. The combination of the PCR-generated mutation together with the mutant version at the 6589 site (6589C) creates a recognition site for HhaI. Thus, the presence of the 6589T (wild-type) disrupts the restriction site. Restriction fragments were separated by electrophoresis in 3% agarose gels containing ethidium bromide (0.1 mg/ml).
Analysis of multipotency of mtDNA-repopulated ES cells
The mtDNA-repopulated ES cells (1 Â 10 6 cells) were inoculated subcutaneously into the back of 6-week-old nude mice (JCL, BALB/c-nu/nu; Clea Japan) for testing their multipotency. The resulting teratomas (tumors) were fixed in 30% neutral-buffered formalin, embedded in paraffin and examined histologically after hematoxylin and eosin staining.
Lactate measurement
For determination of fasting blood lactate concentrations, blood was collected from the tail vein after overnight starvation. After oral administration of glucose (1.5 g/kg body weight) to these mice, blood was again collected and lactate concentrations were measured using an automatic blood lactate test meter (Lactate Pro, ARKRAY).
Statistical analysis
We analyzed data with the (unpaired or paired) Student's t-test. Values with P , 0.05 were considered significant.
